dc.creatorJACOB, Cristina M. A.
dc.creatorPASTORINO, Antonio C.
dc.creatorFAHL, Kristine
dc.creatorCARNEIRO-SAMPAIO, Magda
dc.creatorMONTEIRO, Renato C.
dc.date.accessioned2012-10-19T17:34:22Z
dc.date.accessioned2018-07-04T15:09:01Z
dc.date.available2012-10-19T17:34:22Z
dc.date.available2018-07-04T15:09:01Z
dc.date.created2012-10-19T17:34:22Z
dc.date.issued2008
dc.identifierJOURNAL OF CLINICAL IMMUNOLOGY, v.28, suppl.1, p.S56-S61, 2008
dc.identifier0271-9142
dc.identifierhttp://producao.usp.br/handle/BDPI/22478
dc.identifier10.1007/s10875-007-9163-2
dc.identifierhttp://dx.doi.org/10.1007/s10875-007-9163-2
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1619250
dc.description.abstractBoth systemic and organ-specific autoimmune diseases are major manifestations of IgA deficiency (IgAD), the most common primary immunodeficiency. In addition, to discuss the clinical findings of IgAD patients, we proposed a hypothesis to explain the high association with autoimmune phenomena. Based on observations, interactions of monomeric IgA with Fc alpha RI result in a partial phosphorylation of FcR gamma-associated FcaRI, notably in the immunoreceptor tyrosine-based activation motif (ITAM) inducing the recruitment of the SHP-1 tyrosine phosphatase. This leads to deactivation of several activating pathways of the immune system including immunoreceptors that bear ITAM motif and ITAM-independent receptors. Consequently, inflammatory reactions and auto-immune process would be prevented.
dc.languageeng
dc.publisherSPRINGER/PLENUM PUBLISHERS
dc.relationJournal of Clinical Immunology
dc.rightsCopyright SPRINGER/PLENUM PUBLISHERS
dc.rightsrestrictedAccess
dc.subjectIgA deficiency
dc.subjectautoimmunity clinical
dc.subjectevolution
dc.subjectFc receptor
dc.subjectphysiopathology
dc.titleAutoimmunity in IgA deficiency: Revisiting the role of IgA as a silent housekeeper
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución